Fritextsökning
Innehållstyper
-
Orexo vinner långdragen patenttvist
Amerikanska domstolen för överklagande slår fast att bolagets långa patent för Zubsolv är giltigt. Tidigare beslut som förklarade patentet ogiltigt rivs alltså upp.
-
Läkemedelsbolag ratar Trump
Flera tunga ledare har lämnat Donald Trumps industriråd i protest mot presidentens svaga agerande i samband med kravallerna i amerikanska Charlottesville. Tydli...
-
Bakom de gröna ambitionerna
Många läkemedelsföretag inkluderar i dag ett miljötänk i tillverkningen av läkemedel. Men få är villiga att redovisa faktiska siffror i Life Science Swedens enk...
-
Tar bort behovet av levertransplantation
Hittills har den enda botande behandlingen vid akut hepatisk porfyri, AHP, varit levertransplantation. Nu kan det nya läkemedlet givosiran, som fick en priorite...
-
Product Specialist at Gradientech AB, Uppsala
-
Happy exhibitors!
There were fewer vistors this year but most exhibitors are content.
-
Pharmalundensis söker tillstånd för CFS-studie
Vill ge kvicksilverbindande substans till patienter med kroniskt trötthetssyndrom.
-
High hopes for future partnering - the solution for struggling fairs
Business fairs are struggling but the concept of partnering is hotter than ever. By using social media, participants can prepare themselves for the perfect meeting.
-
Fewer visitors but satisfied exhibitors
Biotech Forum Scanlab attracted fewer visitors than in 2008. Exhibition manager Bo Rasmussen is content, claiming that the exhibitors are very satisfied.
-
Laboratory food
VWR exhibits laboratory tools with molecular gastronomy Rotary evaporators and magnetic stirrers - for making food. VWR tries out new ways for the exhibition at...
-
Google satsar på diagnostik
Utvecklar sökverktyg för kroppen.
-
How to get visitors to your booth
Food, ball throwing and laser engraved pens. There are many tricks to attract visitors to the stands at Scanlab.
-
A crash course in IP strategy
"Publish, publish, publish!" Sound familiar? So to meet the researcher's wishes, do you scribble a patent application with lipstick on a napkin and send it in? ...
-
Discovery of new role for leukemia gene
Martin Bergö and his colleagues have studied two gene variants that often occur in acute leukemias. One gene codes for the protein RAS, which accelerates cell d...
-
Ideon - Sweden's oldest science park
Old is not synonymous with boring. Swedens oldest science park Ideon still manages to attract young companies with big ideas. The recipe for success? To continu...
-
Changing e-solutions for clinical trials
Social media and personalized medicine are two factors that will have a great impact on the design and IT-solutions for clinical trials. Unithink is an upcoming...
-
Definite answer with new cancerous gene
A newly discovered cancer gene is enabling the diagnosis of adenoid cystic caranoima using a genetic test.
-
This is Sweden's largest life science region
About 60 percent of all jobs within swedish life science are found in the Stockholm-Uppsala area. This was stated in a report presented at Scanlab & Biotech Forum today.
-
Schizophrenia and bipolar disorder are relatives
Schizophrenia and bipolar disorder have the same genetic causes, according to a study from Karolinska Institutet.
-
Will the industry follow the economic revival?
Welcome to the eleventh Biotech Forum + Scanlab Fair!
-
Time to save for survival
The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.
-
New tools to fight bacteria
Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antib...
-
Life science management for hire
Do you need help getting your biotech company off and running? Camoleon is a new type of consultant that offers help with business and innovation management and...
-
Diagnostics for personalized medicine
Per Matsson from Phadia anticipates changes in the standards for health care. Accordiing to him, expensive new drugs will create a market for more extensive diagnostics.